Lurie Moves To FDA, Becomes Third Public Citizen Staffer With Key Role
This article was originally published in The Tan Sheet
Executive Summary
FDA's appointment of consumer advocate Peter Lurie to an Office of the Commissioner policy post suggests a strategy of bringing in some of the most outspoken critics of both the drug industry and FDA to address public perceptions of the agency